Consolidation Therapy With Hu3S193 for Women With Ovarian, Primary Peritoneal or Fallopian Tube Cancer

NCT01137071 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

29

Enrollment

INDUSTRY

Sponsor class

Stopped Total number of pts expected to be enrolled would not be met.

Conditions

Fallopian Tube Cancer
Ovarian Cancer
Peritoneal Cavity Cancer

Interventions

BIOLOGICAL: Monoclonal antibody Hu3S193

Sponsor

Recepta Biopharma